Hims & Hers Health announced plans to expand to Canada in 2026. Hims will offer generic copies of semaglutide drugs in Canada ...

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

An audit has uncovered major fraud at the region's largest hospital network, and the London Health Sciences Centre has filed ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced ...

Governor General Mary Simon believes mental health isn't being treated with the holistic approach it requires. She points to ...

The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as ...

Hims & Hers Health plans to expand into Canada, timing it with the new availability of the generic weight loss medication on the market for the first time.

Hims & Hers Health, Inc. (NYSE: HIMS) the leading digital health and wellness platform, today announced its plans to bring ...

The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...

Measles cases have sharply risen across the Region of the Americas in 2025, with 2,318 confirmed infections and three ...

Health Canada has issued a health product recall notice for a certain lot of Dr. Nutrition 360 Magnesium 200 mg capsules due to an incorrect non-medicinal ingredient.

With measles outbreaks, avian influenza and syphilis and HIV on the rise, Canada needs to strengthen its disease surveillance ...